A phase 3 trial of Intellia Therapeutics’ in vivo gene-editing therapy lonvoguran ziclumeran (lonvo-z) has hit its primary ...
The high-priority National Security Space Launch Phase 3 missions include six launches in FY2027, nine in FY2028 and 10 in ...
Boehringer Ingelheim’s glucagon/GLP-1 dual agonist has driven 16.6% weight loss at Week 76 of a phase 3 study. While the ...
The Louisiana Department of Transportation and Development is entering phase three of the Jimmie Davis Bridge project.
Phase 2 data from PTC Therapeutics showed that the Novartis-partnered Huntington’s disease asset slowed progression by more ...
The patient death occurred outside the U.S. and was deemed unrelated to Newron Pharmaceuticals’ investigational schizophrenia ...
FDA provided critical guidance for the advancement of CAD-1005 to pivotal Phase 3 in HIT Phase 2 data showed a greater than 25% absolute reduction in thrombotic events when CAD-1005 was added to ...
Relay Therapeutics (NasdaqGM:RLAY) plans to move its lead program, zovegalisib, into Phase 3 development for frontline PI3Ka ...
A prespecified interim analysis showed statistically significant PFS improvement with elranatamab versus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results